2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

622. Lymphomas: Translational – Non-Genetic: Poster II

Program: Poster Abstract Session
Sunday, December 13, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Molecular Testing, Omics Technologies, Bioinformatics, Emerging Technologies, Profiling, Treatment Considerations, Combination Therapy, Drug Development, Biological Therapies, Antibody Therapy, Bispecific Antibody Therapy, Checkpoint Inhibitor, Immunotherapy, Non-Biological Therapies, Radiation Therapy, Adverse Events, Biological Processes, Genomics, Immune Mechanism, Metabolism, Molecular Biology, Multi-Systemic Interactions, Diseases, Lymphoid Malignancies, Lymphomas, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B Cell Lymphoma, T Cell Lymphoma, Indolent Lymphoma, Aggressive Lymphoma, Research, Fundamental Science, Translational Research, Clinical Research, Health Outcomes Research, Real-World Evidence, Study Population, Human, Adult
PAPER

3531 Single-cell spatial protein atlas construction and heterogeneity profiling in the tumor microenvironment of angioimmunoblastic T-cell lymphoma

Hui Jin, MD, PhD, Zihan Liang2, Yi Miao, MD3, Wenyu Shi4, Lei Cao5, Jianyong Li, MD6
1 The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2 The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
3 The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
4 Affiliated Hospital of Nantong University, Nanjing, China
5 The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
6 The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

INTRODUCTION

Angioimmunoblastic T-cell lymphoma (AITL) is a highly aggressive peripheral T-cell lymphoma originating from follicular helper T (Tfh) cells, defined by a markedly complex tumor microenvironment (TME). However, the scarcity of physiologically relevant experimental models has hindered systematic dissection of the spatial architecture and functional crosstalk within the AITL TME.

METHODS

High-dimensional imaging mass cytometry (IMC) was performed on tissue specimens from 84 patients with AITL and 7 healthy donors, profiling approximately 4.69 million cells across 377 regions of interest (ROI). We integrated single-cell phenotyping, homotypic cluster scoring, K-nearest neighbor (KNN)-based spatial analysis, and cellular neighborhood (CN) analysis with clinicopathological features and survival data to delineate the spatial architecture and identify prognostically relevant spatial features. We further analyzed publicly available bulk RNA sequencing (RNA-seq) datasets and in-house single-cell RNA-seq data from lymph node tissues of 16 AITL patients and 3 healthy donors to validate the association between mast cells and CD8+ T cells. 

RESULTS

We constructed a comprehensive single-cell spatial proteomic atlas of the AITL TME, revealing profound cellular heterogeneity and spatially organized immune niches. Spatial analyses uncovered two previously unreported prognostic biomarkers: mast cell spatial distribution phenotypes and LMP1+ endothelial cells.

Notably, the spatial organization of mast cells, rather than their cellular abundance alone, was strongly correlated with clinical outcomes. Tumors with reduced mast cell aggregation exhibited increased infiltration of exhausted CD8+ T cells, indicative of an immunosuppressive microenvironment and significantly poorer survival. Integrative analysis of public bulk RNA-seq and in-house scRNA-seq datasets further corroborated a close association between mast cells and the exhausted CD8+ T cell state.

In addition, LMP1+ endothelial cells constituted a distinct vascular subset associated with disease progression and therapeutic resistance, implicating a previously unappreciated role of Epstein-Barr virus (EBV)-associated vascular remodeling in AITL pathogenesis. Furthermore, spatial neighborhood analysis identified 10 conserved cellular neighborhoods (CNs). Among them, CN1 and CN5 were significantly associated with patient survival, whereas germinal center-associated neighborhoods that preserve normal lymph node architecture were profoundly disrupted in AITL lesions. 

CONCLUSION

This study establishes a single-cell spatial proteomic atlas of the AITL TME, offering a comprehensive landscape of its cellular composition, spatial architecture, and immune organization. We identify mast cell spatial distribution patterns, LMP1+ endothelial cells, and prognostically relevant cellular neighborhoods as novel spatial biomarkers linked to immunosuppression and disease progression. These findings advance our understanding of AITL pathobiology and provide a valuable resource for biomarker discovery and the development of TME-targeted therapeutic strategies.
Hui Jin, MD, PhD: No relevant conflicts of interest to declare.